A Singapore startup is testing its antiviral drug, RetroMAD1, against the SARS-CoV-2 beta-coronavirus that causes COVID-19. A spokesperson for Biovalence Technologies, the company that developed the drug, believes its drug could treat Covid-19.
If you’re lucky enough to have a stash of N95 respirators, a new study from the National Institutes of Health (NIH) can help you extend their life, at least for a little while.
Kössi and Lucky knew the people had COVID-19 before the people did. More remarkably, they knew before the people even began to show symptoms.
SARS-CoV-2 is transmitted person-to-person through respiratory droplets when an infected person coughs or sneezes. But what other bodily fluids might it lurk in?
One veterinarian at an AAHA-accredited hospital was recently bitten by a five-month-old Labrador. She attributes it—at least in part—to the pandemic.
Researchers need your help to find out how COVID-19 is impacting pet care for at-risk pet owners. And they’re willing to compensate you. To a point.
Aerosolization could explain the alarming spike in COVID cases. Is your hospital's ventilation system up to the challenge?
This week: The secret to harmonious pet relationships, pandas and dogs are cute (but not together), and hip surgery gives a Texas camel a new lease on life
Cases of canine housemate aggression spiked when pet owners tried to integrate their new pandemic adoptees into a household where another dog already ruled the roost. Here's how to help clients solve the issue.
Cats who catch COVID seem to be fighting off the virus with naturally developed antibodies. And more of them may have it than we thought.